Which companies overlap with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Green Cross Corporation, AstraZeneca, Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd., GlaxoSmithKline, Qilu Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sichuan-kelun-biotech-biopharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 5 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 5 Phase 3 1 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
SKB264	SKB264	phase 3
Double blind control period A140	Double blind control period A140	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Open single period A140	Open single period A140	phase 3	CD47 inhibitor	CD47	Oncology
KL-A167	KL-A167	phase 3	PD-L1 inhibitor	PD-L1	Oncology
A166	A166	phase 3	PD-L1 inhibitor	PD-L1	Oncology

Therapeutic area mix

Oncology · 3
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Green Cross Corporation · 2 shared drug classes
AstraZeneca · 2 shared drug classes
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Qilu Pharmaceutical Co., Ltd. · 2 shared drug classes
AceLink Therapeutics, Inc. · 1 shared drug class
Abbott · 1 shared drug class
ADvantage Therapeutics · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sichuan-kelun-biotech-biopharmaceutical-co-ltd. Accessed 2026-05-18.